Pages that link to "Q54193004"

The following pages link to Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis. (Q54193004):

Displaying 12 items.

• Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis (Q21136141) (← links)
• Microarray-assisted pathway analysis identifies MT1X & NFκB as mediators of TCRP1-associated resistance to cisplatin in oral squamous cell carcinoma (Q28116304) (← links)
• Differential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel nonsilent metallothionein-1H mutant variant. (Q30336222) (← links)
• Snail-induced epithelial-to-mesenchymal transition of MCF-7 breast cancer cells: systems analysis of molecular changes and their effect on radiation and drug sensitivity (Q35961794) (← links)
• Cellular mechanisms of zinc dysregulation: a perspective on zinc homeostasis as an etiological factor in the development and progression of breast cancer (Q36250275) (← links)
• Functional analysis of the transcription repressor PLU-1/JARID1B. (Q36315263) (← links)
• The anti-tumour agent, cisplatin, and its clinically ineffective isomer, transplatin, produce unique gene expression profiles in human cells (Q37058630) (← links)
• Metallothinein 1E Enhances Glioma Invasion through Modulation Matrix Metalloproteinases-2 and 9 in U87MG Mouse Brain Tumor Model (Q37409881) (← links)
• Mammalian metallothionein in toxicology, cancer, and cancer chemotherapy (Q37913211) (← links)
• The fat and the bad: Mature adipocytes, key actors in tumor progression and resistance. (Q39356609) (← links)
• BCNU-sequestration by metallothioneins may contribute to resistance in a medulloblastoma cell line (Q39960367) (← links)
• [Perspectives for molecular diagnostics exemplified by urothelial bladder carcinoma]. (Q53379524) (← links)